Photobiomodulation Therapy in a Field Test With High-level Rugby Players
Phototherapy (With a Combination of Super-pulsed Laser and LEDs) in a Field Test With High-level Rugby Players
1 other identifier
interventional
12
1 country
1
Brief Summary
Background/Aim: While growing evidence supports the use of photobiomodulation therapy (PBMT) for performance and recovery enhancement, there have only been laboratory-controlled studies. Therefore, the aim of this study was to analyze the effects of PBMT in performance and recovery of high-level rugby players during an anaerobic field test. Methods: It is a randomized, crossover, double-blinded, placebo-controlled trial. Twelve male high-level rugby athletes were recruited in this study. No intervention was performed before the Bangsbo Sprint Test (BST) at familiarization phase (week 1). At weeks 2 and 3, pre-exercise PBMT or placebo were randomly applied to each athlete. PBMT/placebo irradiation was performed at 17 sites of each lower limb, employing a cluster with 12 diodes (4 laser diodes of 905nm, 4 LED diodes of 875nm, and 4 LED diodes of 640nm, 30J per site - manufactured by Multi Radiance Medical™). Average time of sprints, best time of sprints, and fatigue index were obtained from BST. Blood lactate levels were assessed at baseline, and at 3, 10, 30 and 60 minutes after BST. Athletes' perceived fatigue was also assessed through a questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 24, 2015
CompletedFirst Posted
Study publicly available on registry
October 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedFebruary 4, 2016
February 1, 2016
9 months
October 24, 2015
February 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Bangsbo Sprint Test (BST) - Average Time (sec)
The Average Time of sprints performed during entire test (ST mean). This is the one of the variables from BST to evaluate performance.
The test was performed for three weeks, once a week, on the same day and time of the week.
Bangsbo Sprint Test (BST) - Best Time (sec)
The fastest (best) time (ST best) among the seven sprints performed at each test. One of the variables from BST to evaluate performance.
The test was performed for three weeks, once a week, on the same day and time of the week.
Bangsbo Sprint Test (BST) - Fatigue Index (%)
Fatigue index was calculated by the following equation: FI(%)= (STmean / STbest x 100) ˗ 100 to measure the percentage of decrease in performance between all sprints. One of the variables from BST to evaluate performance.
The test was performed for three weeks, once a week, on the same day and time of the week.
Secondary Outcomes (2)
Questionnaire of fatigue
This questionnaire was answered for the participants in the last day of the tests, so, at the end of the third week of the tests.
Blood Lactate analysis
Blood sample was collected in the three phases of the study (three weeks, once a week) at 3, 10, 30 and 60 minutes after BST.
Study Arms (2)
Active PBMT
ACTIVE COMPARATORActive PBMT was applied employing MR4 Laser Therapy Systems outfitted with LaserShower 50 4D emitters (both manufactured by Multi Radiance Medical, Solon - OH, USA). The cluster style emitter contains 12 diodes comprising of four super-pulsed laser diodes (905 nm, 0.3125 mW average power, and 12.5 W peak power for each diode), four red LED diodes (640 nm, 15 mW average power for each diode), and four infrared LEDs diodes (875 nm, 17.5 mW average power for each diode).
Placebo PBMT
PLACEBO COMPARATORPlacebo PBMT was applied using the same device that emitted the same sounds and light, but with no effective irradiation.
Interventions
PBMT was applied employing MR4 Laser Therapy Systems manufactured by Multi Radiance Medical, Solon - OH, USA. The cluster emitter contains 12 diodes with four super-pulsed laser diodes (905 nm, 0.3125 mW average power, and 12.5 W peak power for each diode), four red LED diodes (640 nm, 15 mW average power for each diode), and four infrared LEDs diodes (875 nm, 17.5 mW average power for each diode). It was applied in direct contact with the skin to 9 sites on extensor muscles of the knee, 6 sites on knee flexors of the knee, and 2 sites on the calf of both lower limbs. To ensure blinding, the device emitted the same sounds and regardless of the programmed mode (active or placebo).
Eligibility Criteria
You may qualify if:
- high-level athletes from São José Rugby Club (Brazil)
You may not qualify if:
- Athlete would be excluded if the participant presented any skeletal muscle injury
- if athlete took any nutritional supplement or pharmacological agent
- if the athlete presented signs and symptoms of any disease (i.e., neurological, inflammatory, pulmonary, metabolic, oncologic), and
- if the athlete had history of cardiac arrest that could limit performance of high-intensity exercises
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nove de Julholead
- Multi Radiance Medicalcollaborator
- São José Rugby Clubcollaborator
Study Sites (1)
Universidade Nove de Julho
São Paulo, São Paulo, 01504001, Brazil
Related Publications (4)
Antonialli FC, De Marchi T, Tomazoni SS, Vanin AA, dos Santos Grandinetti V, de Paiva PR, Pinto HD, Miranda EF, de Tarso Camillo de Carvalho P, Leal-Junior EC. Phototherapy in skeletal muscle performance and recovery after exercise: effect of combination of super-pulsed laser and light-emitting diodes. Lasers Med Sci. 2014 Nov;29(6):1967-76. doi: 10.1007/s10103-014-1611-7. Epub 2014 Jun 19.
PMID: 24942380RESULTAlbuquerque-Pontes GM, Vieira RP, Tomazoni SS, Caires CO, Nemeth V, Vanin AA, Santos LA, Pinto HD, Marcos RL, Bjordal JM, de Carvalho Pde T, Leal-Junior EC. Effect of pre-irradiation with different doses, wavelengths, and application intervals of low-level laser therapy on cytochrome c oxidase activity in intact skeletal muscle of rats. Lasers Med Sci. 2015 Jan;30(1):59-66. doi: 10.1007/s10103-014-1616-2. Epub 2014 Jun 24.
PMID: 24957189RESULTWragg CB, Maxwell NS, Doust JH. Evaluation of the reliability and validity of a soccer-specific field test of repeated sprint ability. Eur J Appl Physiol. 2000 Sep;83(1):77-83. doi: 10.1007/s004210000246.
PMID: 11072777RESULTJohnston RD, Gabbett TJ, Jenkins DG. Applied sport science of rugby league. Sports Med. 2014 Aug;44(8):1087-100. doi: 10.1007/s40279-014-0190-x.
PMID: 24748460RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ernesto Cesar P Leal-Junior, PhD, PT
University of Nove de Julho
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD candidate
Study Record Dates
First Submitted
October 24, 2015
First Posted
October 28, 2015
Study Start
February 1, 2015
Primary Completion
November 1, 2015
Study Completion
January 1, 2016
Last Updated
February 4, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will share
all data is properly stored in electronic devices and available for possible doubts regarding to methodological procedures or results.